Stay updated with breaking news from Eurekare. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EureKARE participates in DNA Script’s $200 Million Series C Financing Fundraise will accelerate commercial launch of revolutionary enzymatic DNA printing. ....
Gynov SAS announces investment from eureKARE SA eureKARE SA will bring long-term expertise, financial and operational support to GynovFinancing will boost the development of the product pipeline ....
eureKARE launches with $60 million to build and finance next generation biotech companies in Europe B innovation eureKARE accompanied by a hig May 2021: eureKARE ( the Company ), a pioneering new company focused on financing and building next generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology, today announces its launch with a $60 million Series A financing. The financing was supported by high-net worth investors and family offices. eureKARE is focused on two emerging and cutting-edge fields of research that have the potential to disrupt and revolutionize the life sciences industry: the microbiome and synthetic biology. Up to 90% of all diseases can be linked to the dysfunction and imbalance of the microbiome with the field forecast to reach $1.6 billion by 2028 at a CAGR of 21%. Synthetic biology, which comprises gene and cell therapy and industrial applications such as data storage and bioproduction ....